THE ROLE OF I-131-METAIODOBENZYLGUANIDINE (MIBG) IN INTESTINAL CARCINOIDS

被引:0
|
作者
BIHL, H
SAUTTERBIHL, ML
WILHELM, KR
KIMMIG, B
机构
来源
NUCLEAR MEDICINE-NUKLEARMEDIZIN | 1987年 / 26卷 / 06期
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:263 / 267
页数:5
相关论文
共 50 条
  • [41] RADIONUCLIDE THERAPY OF PHEOCHROMOCYTOMAS AND NEUROBLASTOMAS USING I-131 METAIODOBENZYLGUANIDINE (MIBG)
    BRENDEL, AJ
    JEANDOT, R
    GUYOT, M
    LAMBERT, B
    DROUILLARD, J
    CLINICAL NUCLEAR MEDICINE, 1989, 14 (01) : 19 - 21
  • [42] COMPARISON OF I-131-METAIODOBENZYLGUANIDINE SCINTIGRAPHY AND OF URINARY AND PLASMA-CATECHOLAMINE DETERMINATION IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA
    PLEWE, G
    BEYER, J
    KRAUSE, U
    CORDES, U
    EISSNER, D
    HAHN, K
    ACTA ENDOCRINOLOGICA, 1985, 108 : 51 - 51
  • [43] COMPARISON OF I-131-METAIODOBENZYLGUANIDINE SCINTIGRAPHY WITH URINARY AND PLASMA-CATECHOLAMINE DETERMINATIONS IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA
    PLEWE, G
    BEYER, J
    KRAUSE, U
    CORDES, U
    EISSNER, D
    HAHN, K
    KLINISCHE WOCHENSCHRIFT, 1985, 63 (14): : 627 - 630
  • [44] The role of 131-I-metaiodobenzylguanidine (13II-MIBG) therapy in irresectable and compromising localized neuroblastoma
    Schoot, R. A.
    Bleeker, G.
    Heij, H. A.
    van Eck, B. L.
    Caron, H. N.
    de Kraker, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] UPTAKE OF I-131-METAIODOBENZYLGUANIDINE BY 6-23 RAT MEDULLARY-THYROID CARCINOMA
    POSTON, GJ
    FAWCETT, HD
    TOWNSEND, CM
    JAMES, E
    LIEG, JL
    NUSYNOWITZ, ML
    THOMPSON, JC
    LIFE SCIENCES, 1989, 44 (21) : 1611 - 1616
  • [46] I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma
    Sato, Yuya
    Kurosawa, Hidemitsu
    Fukushima, Keitaro
    Okuya, Mayuko
    Hagisawa, Susumu
    Sugita, Kenichi
    Arisaka, Osamu
    Inaki, Anri
    Wakabayashi, Hiroshi
    Nakamura, Ayane
    Fukuoka, Makoto
    Kayano, Daiki
    Kinuya, Seigo
    ITALIAN JOURNAL OF PEDIATRICS, 2012, 38
  • [47] Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours -: Experience of the National Cancer Institute of Milan
    Castellani, MR
    Chiti, A
    Seregni, E
    Bombardieri, E
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 2000, 44 (01): : 77 - 87
  • [48] I-131-METAIODOBENZYLGUANIDINE UPTAKE IN THE ISOLATED RAT LUNG - A POTENTIAL MARKER OF ENDOTHELIAL-CELL FUNCTION
    SLOSMAN, DO
    DAVIDSON, D
    BRILL, AB
    ALDERSON, PO
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 13 (10): : 543 - 547
  • [49] THE PROGRESSIVE AND DIFFUSE NATURE OF NEURO-BLASTOMA - TREATMENT WITH I-131 METAIODOBENZYLGUANIDINE (I-131 MIBG)
    SHEN, SW
    SISSON, JC
    HUTCHINSON, R
    SHAPIRO, B
    SHULKIN, B
    GEATTI, O
    MALLETT, S
    EYRE, P
    MANGNER, T
    BEIERWALTES, WH
    JOURNAL OF NUCLEAR MEDICINE, 1985, 26 (05) : P75 - P76
  • [50] Comparing diagnostic performance of I-131-metaiodobenzylguanidine (I-131-MIBG) and (99)mTc-hydrazinonicotinyl-Tyr(3)-Octreotide ((99)mTc-HYNIC-TOC) in diagnosis and localization of pheochromocytoma and neuroblastoma
    Emami-Ardekani, Alireza
    Mirzabeigi, Arefe
    Fard-Esfahani, Armaghan
    Fallahi, Babak
    Beiki, Davood
    Hassanzadeh-Rad, Arman
    Geramifar, Parham
    Eftekhari, Mohammad
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2018, 26 (02): : 68 - 75